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A total of 289 patJents with w@@aphically de 
tennined coronay artery disease, who exhibited a 
compMeabsenceof~napectorisinthepre+ 
ence of reproducible myocatdial ischemia, were 
studied in a followup investigation. After a#~ ini- 
tial coromwy mogram, anWschemic medication 
was -bed as treatment. After a mean follow- 
up time of A9 years (maximum 13.4 years) ps 
tients were sent a queatiomaire that 8888888d 
any new developmmt of wgina pectods pain and 
cardiacevents.In45ofthesepatientsasecond 
WWW=- afterameanperiodof 
4.2years.Asymptomatiipaticw1tshadaworse 
pfOgWSktlUUl~&gHdjUsted nonnal population. 
Aftew5andlOyears,Sand26%ofthepatienbs, 
respectively, bad died, nanfatal cardiac events 
(my- i-m, bypass fwm~ 0~ percuta 
neous tranduminal -w m!9oplasty) - 
cumdafterband10yearsin19and46%,respee 
tively. A large number of initially asymptomatic 
patients developed mgina pectds pain over the 
follow=up period (24% after 5 yeers, 58% after 10 
yems). Novel wglna pectoris pain often pleceded 
cardiac events by months to yeara Multiifiate 
analysis indiied that vessel disease (p = 
0.0001) and degree of ischemia (delhed by ST- 
segment depredon free exercise tolerwce, 
p = 0.04) proved to have independent predictive 
value with respect to mortality rate. Newly devel- 
oped~napectoriswasassociatedwithani~ 
crease in ObJective signs of myocardial ischemia . 
anda- in-rystenosis.lBere 
sult8 i@kate that patients who ohginally had my- 
oeardialischemiawithamarkedabsenceofpain 
can develop angina pectotis over me course of 
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years and that newly developed pain often pre 
cedes cardiac even& 
(Am J Catdid 1993;72:121-127) 
S ome patients with coronary artery disease and myocardial &hernia have a marked lack of angi- na pectoris pain. The reasons for this absence of 
pain remain unclear. A series of investigations have 
shown that these patients have increased pain tbresh- 
olds,‘” which suggest hat the endogenous pain modifi- 
cation system may play a role. The questions that arise 
are whether these patients remain asymptomatic or 
develop angina pectoris pain on a long-term basis, and 
to what extent does pain precede cardiac events? 
METHODS 
AsymptomaticpMentswihmyocardalischemk 
From January 1976 to June 1987, 508 patients were 
admitted to our hospital. These patients fulfilled the fol- 
lowing criteria: In all patients coronary angiography was 
performed, and showed significant coronary artery dis- 
ease (i.e., 250% stenosis in at least 1 of the 3 main coro- 
nary vessels). In no patient had coronary angiography 
been performed before. Patients with valvular disease 
were excluded from the study. In all patients Z2 exer- 
cise tests (on average, 3.2 exercise tests per patient) were 
performed within a 3-month tune period before coronary 
angiography, each of which showed significant signs of 
myocardial ischemia, without patients exhibiting any 
chest pain. Exercise tests were performed with the 
patient supine using a commercially available cycle 
ergometer (Elema Schonander) with a stepwise increas- 
ing watt level. Anti-ischemic medication was stopped 
the day before testing. In all patients, marked myocar- 
dial ischemia was demonstrated by a signiticant ST-seg- 
ment depression (20.1 mV) in exercise electrocardiog- 
raphy tests. In 371 of the 508 patients (73%) the pres- 
ence of myocardial ischemia was additionally evidenced 
by a significant increase in pulmonary capillary wedge 
pressure during floating catheter examination under 
physical exercise, at which time no patient reported 
chest pain. In addition to reproducible substantial silent 
myocardial ischemia during exercise testing, all patients 
reported acomplete absence of angina pectoris pain dur- 
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TABLE I Baseline Data of Asymptomatic Patients at Time of 
Initial Coronary Angiography 
No. of patients (men/women) 
Age (years) 
Height (cm) 
Weight (kg) 
Risk factors 
Cigarette smoking 
Hypertension (> 160/95 mm Hg) 
Hyperlipidemia (> 200 mg/dl total 
cholesterol) 
Diabetes mellitus 
Exercise electrocardiogram 
Exercise tolerance (W) 
Max. heart rate (beats/min) 
Max. blood pressure 
systolic (mm Hg) 
diastolic (mm Hg) 
Max. ST-segment depression (mV) 
Floating catheter examination 
Exercise tolerance (W) 
Pulmonary capillary wedge pressure (mm Hg) 
At rest 
Maximal 
Max. ST-segment depression (mV) 
No. of major coronary arteries 
narrowed > 50% in diameter at angiogram 
1 
2 
3 
Left ventriculogram 
Ejection fraction 
Left ventricular function 
Normal 
Minimally impaired 
Severely impaired 
Previous myocardial infarction 
Heart volume (ml) 
Heart volume related to body weight (ml kg-‘) 
Max. = maximal. 
389 (368/21) 
50.3 + 0.4 
172.5 ? 0.3 
75.4 2 0.5 
272 (70%) 
179 (46%) 
266 (68%) 
68 (18%) 
81 2 2 
126 ‘- 1 
190 AZ 2 
105 2 1 
0.22 t 0.01 
93.6 + 1.7 
9.75 + 0.22 
26.7 + 0.5 
0.29 f 0.01 
131(34%) 
118 (30%) 
140 (36%) 
59.6 + 7.4 
67 (17%) 
190 (49%) 
132 (34%) 
335 (86%) 
882 f 8.5 
11.7 + 0.09 
ing everyday activity in the 3-month period before coro- 
nary angiography. A total of 53% (n = 271) of these 
patients were completely asymptomatic and never expe- 
rienced chest pain during everyday activities, and in 
47% (n = 237) occasional reports of chest pain were evi- 
dent in their past clinical history (23 months before 
coronary angiography). However, it could not be deter- 
mined retrospectively in all cases whether the patients’ 
chest pain reports were due to angina pectoris or to oth- 
er noncardiac causes. These patients were all totally 
asymptomatic 23 months before the first coronary an- 
giogram and were thus included in the present investi- 
gation. 
One hundred nineteen of the 508 patients underwent 
coronary artery bypass surgery or percutaneous translu- 
minal coronary angioplasty during a 6-month period 
after coronary angiography. These patients were exclud- 
ed from the present study. In the remaining patients 
(n = 389) anti-ischemic medication was prescribed as 
treatment, and administered by the treating practitioners 
in most cases. These patients have been investigated in 
the present study. Table I lists coronary angiographic 
data, functional results and risk factors at the time of the 
initial angiogram. 
A total of 86% of these patients (n = 335) already 
had myocardial infarction in their clinical history (% 
weeks before the coronary angiogram). On average, pa- 
tients had pronounced myocardial ischemia with a sub- 
stantial mean ST-segment depression of 0.22 mV and a 
mean maximal pulmonary capillary wedge pressure of 
26.7 mm Hg. Only 18% of these patients had diabetes 
mellitus. 
Procedure: After a mean follow-up period of 4.9 
years (maximum 13.4), all 389 patients were sent a 
questionnaire, which assessed current medical treatment, 
the presence and frequency of chest pain, the point in 
time when, if at all, chest pain developed and under 
which circumstances, and whether myocardial infarction 
had occurred since coronary angiography, or whether 
bypass surgery or percutaneous transluminal coronary 
angioplasty was performed (>6 months after the initial 
coronary angiogram). The patients were asked to con- 
sult their treating practitioner in cases of uncertainty 
while responding to the questionnaire. Patients or their 
practitioners were consulted by telephone in cases of 
unclear esponses to items in the questionnaire. Thus, we 
obtained a reliable estimate of the long-&m follow-up 
in 98% of all cases. 
The new development of angina pectoris pain was 
detined as the point in time (with a precision of a cou- 
ple of months) when chest pain could be provoked in 
exercise tests for the first time (in most cases) and/or 
when the h-eating practitioner observed signs of angina 
pectoris in his/her patients. 
If any patient died during follow-up, the circum- 
stances of death were documented by a telephone call 
to the treating practitioner or to close relatives. The time 
of death was determined and whether symptoms oc- 
curred before death (>l hour), or whether sudden death 
occurred (no symptoms or symptqms occurring within 1 
hour before death). It was also determined whether in 
the months or years before death any new development 
of angina pectoris pain was observed. 
A subgroup of patients (n = 48) underwent a second 
coronary angiography after a mean follow-up period of 
4.2 years (maximal 12 years). This second angiography 
was performed in patients whose increase in myocardial 
ischemia was evident during exercise tests or in those 
whose maximal exercise capacity was markedly re- 
duced, or exercise-induced angina pectoris had devel- 
oped or any combination of these. Results of the second 
angiogram were compared with those of the tit. It was 
determined whether the tidings had changed or whetb- 
er a regression or progression (a change of 22 degrees 
within the classification of the American Heart Associ- 
ation6) of stenoses was evident. 
~atrr analysis: The follow-up data were analyzed 
according to the method of Cutler and Ederer.7 An 
analysis of the prognostically relevant factors was con- 
ducted using the Cox hazards model.8 A McNemar chi- 
square test was performed for testing symmetric distri- 
bution? All values are presented as mean f 1 SEM. 
RESULTS 
Asymptomatic patients with myocardial ischemia had 
a higher mortality rate over the follow-up period than 
the age-adjusted normal population.1o Five years after 
the initial coronary angiography, 9% of these patients 
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had died, and approximately 26% died after 10 years 
(Figure la). A total of 3 patients died of noncardiac rea- 
sons. In the first 5 years, the annual mortality rate was 
relatively low (lJ%/year), and after the sixth follow-up 
year it was somewhat more pronounced (3.4%/year). 
Figure lb shows the incidence of nonfatal cardiac 
events in the surviving patients. In most cases the cardi- 
ac event was myocardial infarction (76%), and bypass 
surgery (17%) or percutaneous transluminal coronary 
angioplasty (7%). The annual nonfatal cardiac event rate 
was 3.7%/year for the First 5 years and afterward 5.6%/ 
year. 
Figure lc shows the new development of angina pec- 
toris pain. A high percentage (after 5 years 34%, after 
10 years 58%) of the patients who were initially asymp- 
tomatic during all exercise tests and during the 3-month 
period before coronary angiography developed angina 
pectoris pain during the follow-up period (5.8%/year). 
In 27% of the cases, nonfatal cardiac events were 
preceded by newly developed angina pectoris pain, 
which occurred months to years before the event (Table 
II). In 30% of the cases, angina pectoris pain occurred 
approximately at the same time as the nonfatal cardiac 
event (in most cases myocardial infarction), whereas 
newly occurring angina pectoris often preceded myocar- 
dial infarction by several days. 
sels (i 1OklOl), (b) leftlvenkikular function (p lO.O05), 
Figure 2 presents the mortality rates for patients who 
were mouned according to (a) number of diseased ves- 
TABLE II Outcome of 389 Initially Asymptomatic Patients with 
Reproducible Myocardial lschemia During Follow-Up 
New developed angina 
pectoris 
Nonfatal cardiac 
event 
Death 
No. % Per Year 
132 5.8 
99 4.6 
54 2.6 
Angina Pectoris 
Preceded Cardiac 
Event or Death 
27 (27%) 
28 (52%) 
(c) maximal ST-segment depression during exercise test- 
ing (p lO.OOS), and (d) ST-segment depression free exer- 
events. -
cise tolerance (i.e., exercise tolerance with ST-segment 
depression of ~0.1 mV; p 50.01). Patients with a 3-ves- 
se1 disease, substantially impaired left ventricular func- 
tion or pronounced ST-segment depression, or a combi- 
nation of these, had the worst prognosis. Table III com- 
pares different factors with respect o their prognostic 
relevance. In a univariate analysis, vessel disease, left 
ventricular function, maximal ST-segment depression 
and ST-segment depression free exercise tolerance had 
a sign&ant predictive value for mortality rate, and in 
part for nonfatal cardiac events. In a multivariate analy- 
sis, vessel disease accounts for most of the variance. 
However, ST-segment depression free exercise tolerance 
also had an independent predictive value with respect o 
mortality rate and to the incidence of nonfatal cardiac 
(ye=4 
0 1 2 3 4 5 6 7 8 9 10 1112 
60 - 
a) Mortality 
70 - II age-adjusted normal population 
80 - . asymptomatlcpatients 
90 
100 t 
01 2 3 4 5 6 7 8 9 10 11 12 
80 C) Development Of anghla peclorls pain 
90 
100 
(year.9 
0 1 2 3 4 5 6 7 0 9 10 1112 
wears) 
50 - 
60 - b) Non-fatal cardiac events 
70 
80 
90 
100 t 
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The new incidence of angina pectoris pain was also 
dependent on the severity of vessel disease (Table III). 
pain significantly more often during the follow-up peri- 
od than did patients with l- and 2-vessel disease (p 
Patients with 3-vessel disease developed angina pectoris 50.05). Angina pectoris pain occurred more frequently 
TABLE III Univariate and Multivariate Analysis of Prognostically Relevant Variables 
According to the Cox Hazards Model 
Mortality rate 
Vessel disease 
Lefl ventricular function 
Heart volume 
Maximal ST-segment depression 
ST-segment depression 
Free exercise tolerance 
Maximal exercise tolerance 
Nonfatal cardiac events 
Vessel disease 
Left ventricular function 
Heart volume 
Maximal ST-segment depresslon 
ST-segment depression 
Free exercise tolerance 
Maximal exercise tolerance 
Development of angina pectoris paln 
Vessel disease 
Left ventricular function 
Heart volume 
Maximal ST-segment depression 
ST-segment depression 
Free exercise tolerance 
Maximal exercise tolerance 
Univariate Multivariate 
x2 p Value X2 p Value 
17.99 0.0000 15.88 0.0001 
5.1 0.02 
1.55 NS 
6.02 0.01 
6.36 0.01 4.24 0.04 
3.14 (0.08) 
16.18 0.0001 15.27 0.0001 
0.11 NS 
2.11 NS 
3.82 0.05 
4.16 0.04 3.26 (0.07) 
1.62 NS 
11.85 0.0006 11.85 0.0006 
0.9 NS 
0.1 NS 
2.8 (0.09) 
1.2 NS 
0.63 NS 
0 1 2 3 4 5 6 7 6 9 10 11 12 0 1 .2 3 4 5 6 7 8 9 10 11 12 
a) Vessel disease 
50 
60 
70 
80 
90 
b) Lefi ventricular function 
n normal 
+ minlmslly Imp&red 
A severely impaired 
0 I 2 3 4 5 6 7 6 9 10 11 12 0 1 2 3 4 5 6 7 8 9 10 11 12 
IPW 
20 - 
30 - 
40 - 
50 - 
60 c) ST-segment depression - 60 . d) ST-segment depression . 50.2 mV free exercise tolerance 
7o - l >O.ZmV 70 - . >MwattS 
60 - 60 . <50 watts - 
90 - 90 - 
100 - 100 - 
FlWRE2.Mo1talRyrateofarymptomrtlc patientslfldependencyOn~~~~VeS6ElQlrcwso(~),~ 
venb9cubr functlon (b), ST%egment ckpreaskn In exercise tests (c), and BFs@wnt delmS8h fmeexerclse tekrmw OfI. 
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during the follow-up period if the patient reported occa- 
sional chest pain in his clinical history before coronary 
angiography (p 10.001; Figure 3). Among these patients 
(n = 221; 58% of the entire group) 50 and 70% after 5 
and 10 years, respectively, reported angina pectoris pain. 
Patients who had never experienced angina pectoris pain 
(n = 168; 42% of the entire group), however, also devel- 
oped anginal pain during the follow-up period (20% 
after 5 years, 47% after 10 years; Figure 3~). The occa- 
sional report of chest pain in the patients’ past clinical 
history had no prognostic value with respect o mortal- 
ity rate or the incidence of nonfatal cardiac events (Fig- 
ure 3, a and b). 
Figure 4 shows the functional parameters measured 
during exercise testing, a comparison of the coronary 
angiographic data, and the development of angina pec- 
tot-is pain in the subgroup of 48 patients whose second 
coronary angiogram was obtained an average of 4.2 
years after the first angiogram. During this time period, 
objective signs of myocardial ischemia had increased 
(maximal pulmonary capillary wedge pressure and max- 
imal ST-segment depression) and exercise capacity had 
decreased in these patients. The results of the second 
angiogram indicated no regression in any patient, no 
change in 37% and a progression of coronary stenoses 
in 63%. Half of these patients reported angina pectoris 
pain during exercise testing before the second angio- 
gram, whereas all these patients experienced no pain 
during exercise testing before the first angiogram. As 
shown by the McNemar &i-square test,9 there was no 
difference between the patients who developed angina 
pectoris and asymptomatic patients with regard to pro- 
gression of coronary stenosis. 
During the follow-up period 54 patients died. More 
than half of the patients (52%) who were asymptomat- 
ic at the time of the initial coronary angiogram devel- 
oped angina pectoris, frequently several years before 
death (Table ff). Only 48% of the patients remained 
asymptomatic until the time of death. In these latter 
patients, 55% experienced sudden death and in another 
25% symptoms frrst occurred ~24 hours before death. 
However, 43% of patients who had developed angina 
pectoris pain some time before death experienced sud- 
den death, and another 21% had occurrence of symp- 
toms ~24 hours before death. The frequency of sudden 
cardiac death did not differ between patients with and 
without newly developed angina pectoris pain as shown 
by the McNemar chi-square test.9 
DISCUSSION 
Coronary patients with myocardial ischemia indicate 
a worse prognosis than an age-adjusted normal popula- 
tion, even when they do not experience angina pectoris. 
This result of the present investigation is in agreement 
with observations of other investigators.“-l6 The annu- 
al mortality rate of the patients investigated here is <2%, 
at least in the tirst years. The patients studied in this 
study represent a select group; most were treated with 
an anti-ischemic medication. At the time patients re- 
sponded to the questionnaire, 72% were receiving anti- 
ischemic medication (nitrates, p blockers, and/or calci- 
um antagonists). Of these patients, 46% were being 
0 1 2 3 4 5 6 7 8 9 10 ill; 
0 
1: 
20 
30 
40 
50 
60 - a) Mortality rate 
70 n - clinical hlstory- 
q 
80 
clinical history+ 
- 
90 - 
100 - 
0 1 2 3 4 5 6 7 8 9 10 11 12 
(Y-4 
0 
% 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
0 1 2 3 4 5 6 7 8 9 10 11 12 
b) Non-fatal cardiac events 
l clinical history- 
0 clinical history+ 
30 - 
40 - 
50 - 
60 . 
70 - c) Developmentof 
80 
angina pactoris pain 
- 
. clinical history- 
90 
t 
A clinical history+ 
100 
FIGURE 3. Mortality rate (a), mmfetal cardiac events fb), and development of m&m pecbris pain (c) dqmdent on the 
~orabsenceofchestpainin~dinicalhi~~33sbefaretheinitial - Tm3-l. 
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treated with a single substance, 39% with 2 of these sub- 
stances, and 15% received all 3 substances. 
The results indicate that the main factors that .have 
earlier been found to determine the course of coronary 
artery disease in symptomatic patients (i.e., vessel dis- 
ease and left ventricular function17-22), also have a sub- 
stantial predictive value in asymptomatic patients. This 
linding is in agreement with studies examining asymp- 
tomatic patients. ‘*J~J~ The severity of myocardial is- 
chemia, delined by the degree of ST-segment depression 
free exercise tolerance, has an independent predictive 
value in asymptomatic patients, as has also been report- 
ed by other investigators. 13,23 This was revealed by a 
multivariate analysis in which the independent contribu- 
tions to the explained variance of mortality rate was 
computed. This observation suggests that the extent to 
which treatment should be given to asymptomatic pa- 
tients should, at least in part, be oriented according to 
the degree of myocardial ischemia. In this study, we 
could not determine whether this suggestion would im- 
prove the asymptomatic patient’s prognosis. This would 
require controlled prospective follow-up studies. The 
present results indicate that the degree of ischemia for 
asymptomatic patients is best represented by the exer- 
cise level reached before a significant ST-segment de- 
pression occurs and not by maximal exercise capacity. 
Because exercise testing in asymptomatic patients is not 
limited by angina pectoris pain, maximal exercise ca- 
pacity did not show an independent predictive value. 
The lack of an independent predictive value for left ven- 
tricular function in the multivariate analysis of the pres- 
ent patient sample is most likely due to our selection cri- 
teria. One of the selection criteria was that the patients 
had a pronounced objective sign of myocardial ischemia. 
In patients with severely impaired left ventricular func- 
tion, the objective signs of myocardial ischemia re often 
equivocal, thus leading to their exclusion from the pre- 
sent study. 
Patients with myocardial ischemia, who were origi-, 
nally asymptomatic, do not remain asymptomatic in 
long-term follow-up studies. A large portion of these pa- 
tients develop angina pectoris, which is in agreement 
with the observations of other workers.11s263o The de- 
velopment of pain often precedes cardiac events by Sev- 
eral months to years. The results from patients who re- 
ceived a second angiogram indicate that the develop- 
ment of pain is associated with a progression of cor- 
onary stenosis and an increase in the objective signs of 
ischemia. According to these observations, it can also be 
assumed that in patients who exhibit a pronounced ab- 
sence of pain during ischemia, astimulus-intensity mech- 
anism plays a role. For such extremely asymptomatic 
patients, our earlier investigation&* and those of other 
research groups3” could demonstrate levated pain 
thresholds. If the intensity of myocardial ischemia in- 
creases in the individual course of an originally asymp- 
tomatic patient, then this more severe ischemia appar- 
ently is sufficient o exceed the elevated pain threshold. 
Compared with symptomatic patients, asymptomatic 
patients have higher pain thresholds, requiring a more 
pronounced myocardial ischemia as a peripheral noci- 
ceptive stimulus to evoke pain. 
It remains uncertain why asymptomatic and sympto- 
matic patients with myocardial ischemia differ in their 
general sensibility to painful stimuli. The observation 
that patients who originally were characterized by a 
marked lack of pain over time also develop angina pec- 
toris pain, suggests that regulative and quantitative fac- 
tors such as individual sensibility to nociceptive stimu- 
li 3,31 pain modification by endorphines32~33 and changes 
m individual pain thresholds4,34,35 are responsible. 
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